节点文献

Regulation of Zishen Qinggan( Shuangyi) Prescription to Insulin Resistance of GK Rats

免费订阅

【作者】 Chunyu TIANChen XINGHaimei BOLiang ZHUXiaojin LAHuijuan CAOXin YANYuyang YANGXuemei ZHOUJi’an LIYongsen JIA

【Author】 Chunyu TIAN;Chen XING;Haimei BO;Liang ZHU;Xiaojin LA;Huijuan CAO;Xin YAN;Yuyang YANG;Xuemei ZHOU;Ji’an LI;Yongsen JIA;North China University of Science and Technology;

【机构】 North China University of Science and Technology

【摘要】 [Objective] To study the effects of Zishen Qinggan( Shuangyi) Prescription on blood glucose,Hb A1c( glycosylated hemoglobin A1c),C-peptide( C-P),glucagon-like peptide( GLP-1),and α-glucosidase activity in GK( Goto-Kakizaki) rats. [Methods]Selected fasting blood glucose( FBG) > 11. 1mmol/L GK rats and randomly divided into groups: model group,Zishen Qinggan( Shuangyi) Prescription low dosage( ig,400 mg/kg/d),medium dosage( ig,800 mg/kg/d),and high dosage groups( ig,1600 mg/kg/d),and metformin group(ig,85 mg/kg/d). After continuous administration for 28 d,fasting blood glucose(FBG),oral glucose tolerance test(OGTT),Hb A1 c,C-P,GLP-1 and α-glucosidase activity were detected. [Results] Compared with the control group,FBG and Hb A1 c of the model group was significantly higher( P < 0. 01); compared with the model group,Zishen Qinggan( Shuangyi) Prescription could significantly reduce the levels of blood glucose,Hb A1 c,and the elevated blood glucose levels after 120 min of glucose loading in OGTT( P < 0. 05,P < 0. 01),and also can significantly improve the level of C-P,GLP-1( P < 0. 05,P < 0. 01),reduce Homa-IR,and inhibit α-glucosidase activity. [Conclusions]Zishen Qinggan( Shuangyi) Prescription can effectively reduce the blood glucose of GK rats,the action mechanism of which is possibly that it can improve insulin resistance,increase GLP-1 content and inhibit α-glucosidase activity.

【基金】 Supported by Project of Natural Science Foundation of Hebei Province(H2015209025);Scientific and Technological Research Project for Institutions of Higher Education in Hebei Province(QN2015119);Scientific and Technological Research Project of Administration of TCM of Hebei Province(2016070);Student’s Platform for Innovation and Entrepreneurship Training Program of North China University of Science and Technology(X2016069);Pharmacology Analysis Key Laboratory for Prevention and Treatment of Diabetes of Traditional Chinese Medicine in Hebei Province
【所属期刊栏目】 Pharmacological and Toxicological Analyses (2017年03期)
  • 【分类号】R285.5
  • 【下载频次】22
节点文献中: 

本文链接的文献网络图示:

浏览历史:
下载历史: